Pharmaceutical company ‘Viatris’ has begun its global restructuring plans which will affect workers at the Baldoyle-based plant in north Dublin.
Nearly 450 jobs will be lost due to the closure of the plant as 20% of the company’s workforce is to be impacted by the restructuring plans.
The company was established by the merger of two other pharmaceutical companies, Mylan and Upjohn. Viatris announced that it was going to divest or downsize up to 15 manufacturing facilities globally.
The reductions will not be immediate as the majority of the company’s workforce will remain employed until late 2022.